Athulitha Laboratories Private Limited (ALPL), with CIN: U24232AP2011PTC077058, was incorporated in 2011 under the Companies Act, 1956, at Hyderabad, Telangana, India. The company commenced operations in FY 2014-2015.
Originally focused on drug intermediates, Athulitha is now expanding to produce high-quality veterinary APIs for domestic and international markets. Committed to becoming a leader in the global veterinary pharma industry, Athulitha offers top-quality products that meet stringent regulatory standards. The company continues to manufacture drug intermediates alongside its new focus.
Therapeutic Areas:
- Anthelmintic
- Antiprotozoal
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Beta-Adrenergic Agonists
- Phosphorus Supplements
- Antibiotics
- Antiparasitic
Athulitha distinguishes itself through strategic vertical and horizontal integration, balancing its portfolio, and managing profitable growth. The company produces products in an eco-friendly, pollution-free environment, adhering to validated procedures.
Focusing on veterinary APIs and drug intermediates, Athulitha is dedicated to enhancing animal health and well-being, contributing to global healthcare with integrity and excellence.
THE COMPANY HAS ONE MANUFACTURING FACILITY
ALPL Unit-I for manufacturing Pharma Intermediates was set up at Plot No: 34/A, Survey No: 298 & 300, S V Co-operative Industrial Estate, IDA Jeedimetla, Hyderabad, Telangana State in FY 2014-2015. The facility was subsequently upgraded to manufacture Veterinary APIs in FY 2024-2025. This unit is ISO 9001:2015 certified and has a GMP facility.